Evidence map›Paper›PMID 21168769›Full record

ArticleChemistry & biology2010

Consequences of cisplatin binding on nucleosome structure and dynamics.

Ryan C Todd, Stephen J Lippard

Open access · greenAbstract read
In one paragraph

Article in Chemistry & biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Cisplatin in Liver Cancer Therapy.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Review
  6. Simultaneous mass spectrometry analysis of cisplatin with oligonucleotide-peptide mixtures: implications for the mechanism of action.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2022
    Article
  7. Article
  8. Review
  9. Functional Diversity of Non-Histone Chromosomal Protein HmgB1.International journal of molecular sciences · 2020
    Review
  10. DNA-Histone Cross-Links: Formation and Repair.Frontiers in cell and developmental biology · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Third row transition metals for the treatment of cancer.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ryan C ToddDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Stephen J Lippard
Massachusetts Institute of Technology · US

Funding

Y-FAMILY POLYMERASES AND CO-FACTORS IN TRANSLESION REPLICATIONP41RR015301 · NCRR · CORNELL UNIVERSITY ITHACA · PI EISENBERG, DAVID · 2001 to 2011
$28.2M
Understanding and Improving Platinum Anticancer DrugsR01CA034992 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YILMAZ, OMER · 1985 to 2018
$6.8M
CHEMISTRY AND BIOLOGY OF PLATINUM ANTICANCER DRUGSR37CA034992 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LIPPARD, STEPHEN J. · 1990 to 2008
$5.7M
NCI NIH HHS CA034992NCI NIH HHS R01 CA034992NCI NIH HHS R37 CA034992NCRR NIH HHS P41 RR015301NCRR NIH HHS RR-15301
6 · The paper itself

Abstract

The effects of cisplatin binding to DNA were explored at the nucleosome level to incorporate key features of the eukaryotic nuclear environment. An X-ray crystal structure of a site-specifically platinated nucleosome carrying a 1,3-cis-{Pt(NH₃)₂}²+-d(GpTpG) intrastrand cross-link reveals the details of how this adduct dictates the rotational positioning of DNA in the nucleosome. Results from in vitro nucleosome mobility assays indicate that a single platinum adduct interferes with ATP-independent sliding of DNA around the octamer core. Data from in vitro transcription experiments suggest that RNA polymerases can successfully navigate along cisplatin-damaged DNA templates that contain nucleosomes, but stall when the transcription elongation complex physically contacts a platinum cross-link located on the template strand. These results provide information about the effects of cisplatin binding to nuclear DNA and enhance our understanding of the mechanism of transcription inhibition by platinum anticancer compounds.

Indexed as

Antineoplastic AgentsCisplatinCrystallography, X-RayDNADNA AdductsDNA-Directed RNA PolymerasesMolecular Dynamics SimulationNucleosomesProtein BindingTranscription, GeneticViral ProteinsAntineoplastic Agentsbacteriophage T7 RNA polymeraseCisplatinDNADNA AdductsDNA-Directed RNA PolymerasesNucleosomesViral Proteins

Identifiers

PMID21168769
PMCPMC3008157
OpenAlexW1481579168

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.